drugset / Trial / NCT01438424
Safety and Antiviral Activity of Entecavir in Participants With Chronic Hepatitis B Following Monotherapy in Other Entecavir Trials
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to provide entecavir to participants who have completed another entecavir trial without achieving virologic response or who relapsed during postdosing follow-up.
Timeline
- Start
- 2001-01
- Primary completion
- 2009-12
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Entecavir | Small molecule | 1 mg | Oral |
| Background | Lamivudine | Other / unclassified | 100 mg | Oral |